Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1652299/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849708942392819712 |
|---|---|
| author | Robert Hoffrogge Anna Karachunskaya Neele Heitmann Steffen Haupeltshofer Xiomara Pedreiturria Katharina Klöster Verian Bader Konstanze F. Winklhofer Michael Hamacher Bert Klebl Ralf Gold Klaus Dinkel Ingo Kleiter Ingo Kleiter Simon Faissner |
| author_facet | Robert Hoffrogge Anna Karachunskaya Neele Heitmann Steffen Haupeltshofer Xiomara Pedreiturria Katharina Klöster Verian Bader Konstanze F. Winklhofer Michael Hamacher Bert Klebl Ralf Gold Klaus Dinkel Ingo Kleiter Ingo Kleiter Simon Faissner |
| author_sort | Robert Hoffrogge |
| collection | DOAJ |
| format | Article |
| id | doaj-art-aae52790dfe9494880d648883cc3d0cc |
| institution | DOAJ |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-aae52790dfe9494880d648883cc3d0cc2025-08-20T03:15:29ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-07-011610.3389/fimmu.2025.16522991652299Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigmRobert Hoffrogge0Anna Karachunskaya1Neele Heitmann2Steffen Haupeltshofer3Xiomara Pedreiturria4Katharina Klöster5Verian Bader6Konstanze F. Winklhofer7Michael Hamacher8Bert Klebl9Ralf Gold10Klaus Dinkel11Ingo Kleiter12Ingo Kleiter13Simon Faissner14Department of Neurology, St. Josef-Hospital, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Bochum, GermanyTranslational Neurology Group, Department of Clinical Science, Lund University, Lund, SwedenDepartment of Neurology, St. Josef-Hospital, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Bochum, GermanyMolecular Cell Biology, Ruhr-University, Bochum, GermanyMolecular Cell Biology, Ruhr-University, Bochum, GermanyAffectis Pharmaceuticals AG, Dortmund, GermanyKHAN Technology Transfer Fund I GmbH & Co KG, Dortmund, GermanyDepartment of Neurology, St. Josef-Hospital, Bochum, GermanyLead Discovery Center GmbH, Dortmund, GermanyDepartment of Neurology, St. Josef-Hospital, Bochum, GermanyBehandlungszentrum Kempfenhausen für Multiple Sklerose Kranke gemeinnützige GmbH, Berg, GermanyDepartment of Neurology, St. Josef-Hospital, Bochum, Germanyhttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1652299/fullP2X7Rprogressive multiple sclerosismicroglianeuroinflammationneuroprotection |
| spellingShingle | Robert Hoffrogge Anna Karachunskaya Neele Heitmann Steffen Haupeltshofer Xiomara Pedreiturria Katharina Klöster Verian Bader Konstanze F. Winklhofer Michael Hamacher Bert Klebl Ralf Gold Klaus Dinkel Ingo Kleiter Ingo Kleiter Simon Faissner Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm Frontiers in Immunology P2X7R progressive multiple sclerosis microglia neuroinflammation neuroprotection |
| title | Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm |
| title_full | Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm |
| title_fullStr | Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm |
| title_full_unstemmed | Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm |
| title_short | Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm |
| title_sort | correction the p2x7r antagonist afc 5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm |
| topic | P2X7R progressive multiple sclerosis microglia neuroinflammation neuroprotection |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1652299/full |
| work_keys_str_mv | AT roberthoffrogge correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT annakarachunskaya correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT neeleheitmann correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT steffenhaupeltshofer correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT xiomarapedreiturria correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT katharinakloster correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT verianbader correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT konstanzefwinklhofer correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT michaelhamacher correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT bertklebl correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT ralfgold correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT klausdinkel correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT ingokleiter correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT ingokleiter correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm AT simonfaissner correctionthep2x7rantagonistafc5128ameliorateschronicexperimentalautoimmuneencephalomyelitisinapreventiveandtherapeuticparadigm |